This page is a trusted source for both professionals and patients, detailing brand-name ... common drugs, giving you a deeper understanding of how these medications work to alleviate Schizophrenia ...

Currently, the drug clozapine is the only option for treatment-resistant schizophrenia ... said Cobenfy will be available in October at a list price of $1,850 per month before insurance and ...

This suggests that these two different classes of schizophrenia drugs may be acting at different components of the same molecular complex. Supporting this notion are several observations.

Boehringer Ingelheim has taken an option on a family of compounds with potential as therapies for schizophrenia ... of all marketed drugs, and Boehringer adds to a growing list of partners that ...

Bristol-Myers Squibb's $14 billion bet on buying Karuna Therapeutics looks set to pay off after it got FDA approval for the schizophrenia drug at the ... the Cobenfy brand name for the treatment ...

DelveInsight’s, “Schizophrenia Pipeline Insight” report provides comprehensive insights about 55+ companies and 60+ pipeline drugs in Schizophrenia pipeline landscape. It covers the ...